These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 25400827)
1. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. Lu W; Xu Z; Zhang M; Zuo Y Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827 [TBL] [Abstract][Full Text] [Related]
2. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. Lu WD; Zuo Y; Xu Z; Zhang M World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465 [TBL] [Abstract][Full Text] [Related]
3. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
4. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Ha GH; Park JS; Breuer EK Cancer Lett; 2013 May; 332(1):63-73. PubMed ID: 23348690 [TBL] [Abstract][Full Text] [Related]
5. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
6. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723 [TBL] [Abstract][Full Text] [Related]
7. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841 [TBL] [Abstract][Full Text] [Related]
8. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187 [TBL] [Abstract][Full Text] [Related]
9. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Liu Z; Zhu J; Cao H; Ren H; Fang X Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
11. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer. Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473 [TBL] [Abstract][Full Text] [Related]
12. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling. Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806 [TBL] [Abstract][Full Text] [Related]
14. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851 [TBL] [Abstract][Full Text] [Related]
15. miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway. Cheng Y; Li Y; Liu D; Zhang R; Zhang J FEBS Lett; 2014 Aug; 588(17):3274-81. PubMed ID: 25064845 [TBL] [Abstract][Full Text] [Related]
16. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401 [TBL] [Abstract][Full Text] [Related]
17. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4. Wang L; Li K; Wang C; Shi X; Yang H Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980 [TBL] [Abstract][Full Text] [Related]
18. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling. Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337 [TBL] [Abstract][Full Text] [Related]
19. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
20. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p. Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]